Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT00468988
Collaborator
(none)
30
1
2
15
Study Details
Study Description
Brief Summary
Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
30 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Study Start Date
:
May 1, 2007
Actual Primary Completion Date
:
Jul 1, 2007
Actual Study Completion Date
:
Jul 1, 2007
Outcome Measures
Primary Outcome Measures
- Tear Break Up Time [Day]
Secondary Outcome Measures
- Safety [Onset]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma
Exclusion Criteria:
- Age
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Orlando | Orlando | Florida | United States | 32801 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Mark Jasek, PhD, Alcon Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00468988
Other Study ID Numbers:
- SMA-06-21
First Posted:
May 3, 2007
Last Update Posted:
May 25, 2012
Last Verified:
May 1, 2012